(RLX) RLX Technology - Overview
Exchange: NYSE •
Country: China •
Currency: USD •
Type: Common Stock •
ISIN: US74969N1037
Stock: E-Vapor, Devices, Pods, Accessories
Total Rating 44
Risk 94
Buy Signal 0.21
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.62% |
| Yield on Cost 5y | 0.53% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 97.5% |
| Payout Ratio | 21.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.7% |
| Relative Tail Risk | -14.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | 7.14 |
| Character TTM | |
|---|---|
| Beta | 0.127 |
| Beta Downside | 0.440 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.89% |
| CAGR/Max DD | 0.14 |
Description: RLX RLX Technology January 12, 2026
RLX Technology Inc. (NYSE:RLX) designs, manufactures, and distributes e-vapor (electronic cigarette) products primarily in the People’s Republic of China, with additional sales through offline distributors to international markets. Founded in 2018 and headquartered in Shenzhen, the firm operates as a common-stock listed company and is classified under the GICS sub-industry “Packaged Foods & Meats,” although its core business is in the vaping sector.
Recent filings (as of FY 2023) show RLX generated roughly $120 million in revenue, up about 15 % year-over-year, driven by expanding retail presence and a modest recovery in Chinese consumer spending on premium nicotine alternatives. The company’s gross margin hovered near 45 %, but net earnings remain negative due to high R&D and marketing spend. Key sector drivers include a projected 14 % CAGR for the global e-vapor market through 2028 and tightening Chinese regulations that favor domestically produced devices over imports, which could benefit RLX if it secures compliance approvals.
For a deeper quantitative dive, the ValueRay platform offers granular financial metrics and peer comparisons that can help you assess RLX’s valuation relative to its growth prospects.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 764.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 3.45 > 1.0 |
| NWC/Revenue: 261.3% < 20% (prev 365.9%; Δ -104.5% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.29b > Net Income 764.3m |
| Net Debt (-3.29b) to EBITDA (219.8m): -14.98 < 3 |
| Current Ratio: 9.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.30b) vs 12m ago 0.58% < -2% |
| Gross Margin: 31.95% > 18% (prev 0.29%; Δ 3166 % > 0.5%) |
| Asset Turnover: 19.35% > 50% (prev 13.59%; Δ 5.75% > 0%) |
| Interest Coverage Ratio: -0.08 > 6 (EBITDA TTM 219.8m / Interest Expense TTM -834.2m) |
Altman Z'' 10.00
| A: 0.49 (Total Current Assets 9.58b - Total Current Liabilities 1.03b) / Total Assets 17.43b |
| B: 0.24 (Retained Earnings 4.25b / Total Assets 17.43b) |
| C: 0.00 (EBIT TTM 70.2m / Avg Total Assets 16.92b) |
| D: 12.99 (Book Value of Equity 16.10b / Total Liabilities 1.24b) |
| Altman-Z'' Score: 17.68 = AAA |
Beneish M -3.34
| DSRI: 0.38 (Receivables 209.6m/376.1m, Revenue 3.27b/2.23b) |
| GMI: 0.90 (GM 31.95% / 28.90%) |
| AQI: 0.96 (AQ_t 0.44 / AQ_t-1 0.45) |
| SGI: 1.47 (Revenue 3.27b / 2.23b) |
| TATA: -0.03 (NI 764.3m - CFO 1.29b) / TA 17.43b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of RLX shares?
As of February 07, 2026, the stock is trading at USD 2.41 with a total of 2,276,914 shares traded.
Over the past week, the price has changed by +4.33%, over one month by +9.36%, over three months by +8.89% and over the past year by +10.73%.
Over the past week, the price has changed by +4.33%, over one month by +9.36%, over three months by +8.89% and over the past year by +10.73%.
Is RLX a buy, sell or hold?
RLX Technology has received a consensus analysts rating of 4.60.
Therefore, it is recommended to buy RLX.
- StrongBuy: 4
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2.9 | 20.3% |
| Analysts Target Price | 2.9 | 20.3% |
| ValueRay Target Price | 2.5 | 3.7% |
RLX Fundamental Data Overview February 02, 2026
Market Cap CNY = 20.39b (2.94b USD * 6.9418 USD.CNY)
P/E Trailing = 28.875
P/E Forward = 8.8652
P/S = 0.8976
P/B = 1.2263
Revenue TTM = 3.27b CNY
EBIT TTM = 70.2m CNY
EBITDA TTM = 219.8m CNY
Long Term Debt = 52.1m CNY (from capitalLeaseObligations, last quarter)
Short Term Debt = 136.1m CNY (from shortTermDebt, last quarter)
Debt = 165.5m CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.29b CNY (from netDebt column, last quarter)
Enterprise Value = 17.10b CNY (20.39b + Debt 165.5m - CCE 3.46b)
Interest Coverage Ratio = -0.08 (Ebit TTM 70.2m / Interest Expense TTM -834.2m)
EV/FCF = 13.24x (Enterprise Value 17.10b / FCF TTM 1.29b)
FCF Yield = 7.55% (FCF TTM 1.29b / Enterprise Value 17.10b)
FCF Margin = 39.46% (FCF TTM 1.29b / Revenue TTM 3.27b)
Net Margin = 23.35% (Net Income TTM 764.3m / Revenue TTM 3.27b)
Gross Margin = 31.95% ((Revenue TTM 3.27b - Cost of Revenue TTM 2.23b) / Revenue TTM)
Gross Margin QoQ = 34.10% (prev 30.48%)
Tobins Q-Ratio = 0.98 (Enterprise Value 17.10b / Total Assets 17.43b)
Interest Expense / Debt = 33.01% (Interest Expense 54.6m / Debt 165.5m)
Taxrate = 18.18% (45.9m / 252.8m)
NOPAT = 57.4m (EBIT 70.2m * (1 - 18.18%))
Current Ratio = 9.30 (Total Current Assets 9.58b / Total Current Liabilities 1.03b)
Debt / Equity = 0.01 (Debt 165.5m / totalStockholderEquity, last quarter 16.10b)
Debt / EBITDA = -14.98 (Net Debt -3.29b / EBITDA 219.8m)
Debt / FCF = -2.55 (Net Debt -3.29b / FCF TTM 1.29b)
Total Stockholder Equity = 16.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.52% (Net Income 764.3m / Total Assets 17.43b)
RoE = 4.74% (Net Income TTM 764.3m / Total Stockholder Equity 16.12b)
RoCE = 0.43% (EBIT 70.2m / Capital Employed (Equity 16.12b + L.T.Debt 52.1m))
RoIC = 0.35% (NOPAT 57.4m / Invested Capital 16.19b)
WACC = 6.55% (E(20.39b)/V(20.56b) * Re(6.38%) + D(165.5m)/V(20.56b) * Rd(33.01%) * (1-Tc(0.18)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.10%
[DCF Debug] Terminal Value 77.35% ; FCFF base≈1.03b ; Y1≈679.2m ; Y5≈309.9m
Fair Price DCF = 12.67 (EV 8.24b - Net Debt -3.29b = Equity 11.53b / Shares 909.7m; r=6.55% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 34.44 | EPS CAGR: -35.03% | SUE: -2.98 | # QB: 0
Revenue Correlation: -14.01 | Revenue CAGR: -15.03% | SUE: 0.08 | # QB: 0
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=+0.014 | Revisions Net=-1 | Growth EPS=+11.2% | Growth Revenue=+30.9%
P/E Trailing = 28.875
P/E Forward = 8.8652
P/S = 0.8976
P/B = 1.2263
Revenue TTM = 3.27b CNY
EBIT TTM = 70.2m CNY
EBITDA TTM = 219.8m CNY
Long Term Debt = 52.1m CNY (from capitalLeaseObligations, last quarter)
Short Term Debt = 136.1m CNY (from shortTermDebt, last quarter)
Debt = 165.5m CNY (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.29b CNY (from netDebt column, last quarter)
Enterprise Value = 17.10b CNY (20.39b + Debt 165.5m - CCE 3.46b)
Interest Coverage Ratio = -0.08 (Ebit TTM 70.2m / Interest Expense TTM -834.2m)
EV/FCF = 13.24x (Enterprise Value 17.10b / FCF TTM 1.29b)
FCF Yield = 7.55% (FCF TTM 1.29b / Enterprise Value 17.10b)
FCF Margin = 39.46% (FCF TTM 1.29b / Revenue TTM 3.27b)
Net Margin = 23.35% (Net Income TTM 764.3m / Revenue TTM 3.27b)
Gross Margin = 31.95% ((Revenue TTM 3.27b - Cost of Revenue TTM 2.23b) / Revenue TTM)
Gross Margin QoQ = 34.10% (prev 30.48%)
Tobins Q-Ratio = 0.98 (Enterprise Value 17.10b / Total Assets 17.43b)
Interest Expense / Debt = 33.01% (Interest Expense 54.6m / Debt 165.5m)
Taxrate = 18.18% (45.9m / 252.8m)
NOPAT = 57.4m (EBIT 70.2m * (1 - 18.18%))
Current Ratio = 9.30 (Total Current Assets 9.58b / Total Current Liabilities 1.03b)
Debt / Equity = 0.01 (Debt 165.5m / totalStockholderEquity, last quarter 16.10b)
Debt / EBITDA = -14.98 (Net Debt -3.29b / EBITDA 219.8m)
Debt / FCF = -2.55 (Net Debt -3.29b / FCF TTM 1.29b)
Total Stockholder Equity = 16.12b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.52% (Net Income 764.3m / Total Assets 17.43b)
RoE = 4.74% (Net Income TTM 764.3m / Total Stockholder Equity 16.12b)
RoCE = 0.43% (EBIT 70.2m / Capital Employed (Equity 16.12b + L.T.Debt 52.1m))
RoIC = 0.35% (NOPAT 57.4m / Invested Capital 16.19b)
WACC = 6.55% (E(20.39b)/V(20.56b) * Re(6.38%) + D(165.5m)/V(20.56b) * Rd(33.01%) * (1-Tc(0.18)))
Discount Rate = 6.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.10%
[DCF Debug] Terminal Value 77.35% ; FCFF base≈1.03b ; Y1≈679.2m ; Y5≈309.9m
Fair Price DCF = 12.67 (EV 8.24b - Net Debt -3.29b = Equity 11.53b / Shares 909.7m; r=6.55% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 34.44 | EPS CAGR: -35.03% | SUE: -2.98 | # QB: 0
Revenue Correlation: -14.01 | Revenue CAGR: -15.03% | SUE: 0.08 | # QB: 0
EPS next Year (2026-12-31): EPS=0.95 | Chg30d=+0.014 | Revisions Net=-1 | Growth EPS=+11.2% | Growth Revenue=+30.9%